Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer

J Gastrointest Cancer. 2009;40(3-4):119-22. doi: 10.1007/s12029-009-9086-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / drug therapy*
  • Clinical Trials, Phase III as Topic
  • Gait Disorders, Neurologic / chemically induced*
  • Gait Disorders, Neurologic / physiopathology
  • Hepatitis, Autoimmune / complications
  • Humans
  • Indoles / adverse effects*
  • Liver Neoplasms / complications
  • Liver Neoplasms / drug therapy*
  • Male
  • Postural Balance / drug effects*
  • Protein Kinase Inhibitors / adverse effects
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / drug effects
  • Pyrroles / adverse effects*
  • Sensation Disorders / chemically induced
  • Sunitinib

Substances

  • Antineoplastic Agents
  • Indoles
  • Protein Kinase Inhibitors
  • Pyrroles
  • Protein-Tyrosine Kinases
  • Sunitinib